The insertion allele at the angiotensin I-converting enzyme gene locus is associated with insulin resistance

被引:52
作者
Chiu, KC
McCarthy, JE
机构
[1] Div. of Endocrinology and Metabolism, Univ. of California, Los Angeles, School of Medicine, Los Angeles, CA
[2] Div. of Endocrinology and Metabolism, UCLA, School of Medicine, Los Angeles, CA 90095-1682, 10833 Le Conte Ave
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 1997年 / 46卷 / 04期
关键词
PROTEIN-KINASE-C; DEPENDENT DIABETES-MELLITUS; DELETION POLYMORPHISM; MOLECULAR-BIOLOGY; GLUCOSE; HYPERINSULINEMIA; CARDIOMYOPATHY; HYPERTENSION; RETINOPATHY; SENSITIVITY;
D O I
10.1016/S0026-0495(97)90054-8
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Plasma angiotensin I-converting enzyme (ACE) levels are genetically predetermined and are correlated with a deletion (D) insertion (I) polymorphism at the ACE gene locus, A subset of diabetic patients are noted to have elevated ACE levels, Treatment with ACE inhibitors has been shown to improve insulin sensitivity in both diabetic and nondiabetic subjects, We examined the relationship of D/I polymorphism and insulin sensitivity in 24 glucose-tolerant subjects by an oral glucose tolerance test (OGTT) and glucose clamps. Subjects with the I allele had higher insulin levels at 90 minutes (515 +/- 69 v 250 +/- 43 pmol/L, P = .008) and higher insulin area under the curve (56,200 +/- 8,148 v 33,300 +/- 8,114, P = .022) after glucose challenge compared with subjects without the I allele. During the euglycemic clamp, subjects with the I allele require less glucose infusion to maintain euglycemia than subjects without the I allele (5.343 +/- 0.743 v 8.944 +/- 1.272 mg/kg/min, p = .020). We conclude that the I allele is associated with insulin resistance in glucose-tolerant and normotensive African-Americans. Copyright (C) 1997 by W.B. Saunders Company.
引用
收藏
页码:395 / 399
页数:5
相关论文
共 40 条
[1]
ALHENCGELAS F, 1991, J LAB CLIN MED, V117, P33
[2]
ALLEMANN Y, 1992, EUR J CLIN PHARMACOL, V42, P275
[3]
Bergemann R., 1992, Schweizerische Medizinische Wochenschrift, V122, P1369
[4]
ANGIOTENSIN-II INCREASES GLUCOSE-UTILIZATION DURING ACUTE HYPERINSULINEMIA VIA A HEMODYNAMIC MECHANISM [J].
BUCHANAN, TA ;
THAWANI, H ;
KADES, W ;
MODRALL, JG ;
WEAVER, FA ;
LAUREL, C ;
POPPITI, R ;
XIANG, A ;
HSUEH, W .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (02) :720-726
[5]
DELETION POLYMORPHISM IN THE GENE FOR ANGIOTENSIN-CONVERTING ENZYME IS A POTENT RISK FACTOR FOR MYOCARDIAL-INFARCTION [J].
CAMBIEN, F ;
POIRIER, O ;
LECERF, L ;
EVANS, A ;
CAMBOU, JP ;
ARVEILER, D ;
LUC, G ;
BARD, JM ;
BARA, L ;
RICARD, S ;
TIRET, L ;
AMOUYEL, P ;
ALHENCGELAS, F ;
SOUBRIER, F .
NATURE, 1992, 359 (6396) :641-644
[6]
Promoter variation in the liver glucokinase is a risk factor for non-insulin-dependent diabetes mellitus [J].
Chiu, KC ;
McCarthy, JE .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 221 (03) :614-618
[7]
GLUCOKINASE GENE IS GENETIC-MARKER FOR NIDDM IN AMERICAN BLACKS [J].
CHIU, KC ;
PROVINCE, MA ;
PERMUTT, MA .
DIABETES, 1992, 41 (07) :843-849
[8]
PROTEIN-KINASE-C - MEDIATOR OR INHIBITOR OF INSULIN ACTION [J].
CONSIDINE, RV ;
CARO, JF .
JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, 52 (01) :8-13
[9]
DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214
[10]
EXPRESSION OF THE MAJOR ISOENZYME OF PROTEIN-KINASE-C IN SKELETAL-MUSCLE, NPKC-THETA, VARIES WITH MUSCLE-TYPE AND IN RESPONSE TO FRUCTOSE-INDUCED INSULIN-RESISTANCE [J].
DONNELLY, R ;
REED, MJ ;
AZHAR, S ;
REAVEN, GM .
ENDOCRINOLOGY, 1994, 135 (06) :2369-2374